src family kinase sfk py416 (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
96
Structured Review
Cell Signaling Technology Inc
src family kinase sfk py416
Src Family Kinase Sfk Py416, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 2354 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho-src+family+(py416)+antibody/Phospho-Src+Family+(Tyr416)+Antibody/pm20583816__cb100099h_si_001-12-10-15
Average 96 stars, based on 2354 article reviews
Src Family Kinase Sfk Py416, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 2354 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho-src+family+(py416)+antibody/Phospho-Src+Family+(Tyr416)+Antibody/pm20583816__cb100099h_si_001-12-10-15
Average 96 stars, based on 2354 article reviews
src family kinase sfk py416 - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Blocking Assay:Article Title: Multicolor Monitoring of Dysregulated Protein Kinases in Chronic Myelogenous Leukemia Article Snippet: .. Primary antibodies against Lyn kinase (sc-7274; Santa Cruz S2 Biotechnology), Membrane:Article Title: Multicolor Monitoring of Dysregulated Protein Kinases in Chronic Myelogenous Leukemia Article Snippet: .. Primary antibodies against Lyn kinase (sc-7274; Santa Cruz S2 Biotechnology), Control:Article Title: Multicolor Monitoring of Dysregulated Protein Kinases in Chronic Myelogenous Leukemia Article Snippet: .. Primary antibodies against Lyn kinase (sc-7274; Santa Cruz S2 Biotechnology), Phospho-proteomics:Article Title: Differential Efficacy of Bevacizumab and Erlotinib in Preclinical Models of Renal Medullary Carcinoma and Fumarate Hydratase-Deficient Renal Cell Carcinoma Article Snippet: .. The catalog number and the phosphorylation site recognized are: pEGFR (3777, pY1068, Cell Signaling, Danvers, MA, USA, RRID:AB_2096270); EGFR (4267, Cell Signaling, RRID:AB_2895042); Immunofluorescence:Article Title: The Aurora B inhibitor ZM-447439 induces caspase-independent necrosis-like death in v-Src oncogene-expressing cells via accumulation of extra-lysosomal cathepsin B. Article Snippet: Src signaling is aberrantly activated in various cancers, and therapeutic strategies targeting Src-dependent cancers have been developed.. We previously reported that cells expressing the oncogenic mutant v-Src are resistant to microtubule-targeting agents (MTAs), yet paradoxically exhibiting sensitivity to the Aurora B inhibitor ZM-447439; however, the mechanism underlying this cytotoxicity remains unclear.. In this study, we demonstrate that the Aurora B inhibitor ZM-447439 potentiates cell death in v-Src-expressing HeLa S3 and HCT116 cells, accompanied by the accumulation of tetraploid and polyploid cells. Western Blot:Article Title: The Aurora B inhibitor ZM-447439 induces caspase-independent necrosis-like death in v-Src oncogene-expressing cells via accumulation of extra-lysosomal cathepsin B. Article Snippet: Src signaling is aberrantly activated in various cancers, and therapeutic strategies targeting Src-dependent cancers have been developed.. We previously reported that cells expressing the oncogenic mutant v-Src are resistant to microtubule-targeting agents (MTAs), yet paradoxically exhibiting sensitivity to the Aurora B inhibitor ZM-447439; however, the mechanism underlying this cytotoxicity remains unclear.. In this study, we demonstrate that the Aurora B inhibitor ZM-447439 potentiates cell death in v-Src-expressing HeLa S3 and HCT116 cells, accompanied by the accumulation of tetraploid and polyploid cells. Flow Cytometry:Article Title: The Aurora B inhibitor ZM-447439 induces caspase-independent necrosis-like death in v-Src oncogene-expressing cells via accumulation of extra-lysosomal cathepsin B. Article Snippet: Src signaling is aberrantly activated in various cancers, and therapeutic strategies targeting Src-dependent cancers have been developed.. We previously reported that cells expressing the oncogenic mutant v-Src are resistant to microtubule-targeting agents (MTAs), yet paradoxically exhibiting sensitivity to the Aurora B inhibitor ZM-447439; however, the mechanism underlying this cytotoxicity remains unclear.. In this study, we demonstrate that the Aurora B inhibitor ZM-447439 potentiates cell death in v-Src-expressing HeLa S3 and HCT116 cells, accompanied by the accumulation of tetraploid and polyploid cells. other:Article Title: Reciprocal regulation of Solo and Src orchestrates Src trafficking to promote mesenchymal cell migration Article Snippet: |
